# Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

> **NCT02059889** · NA · WITHDRAWN · sponsor: **Virginia Commonwealth University**

## Conditions studied

- Recurrent Non-small Cell Lung Cancer
- Stage IIA Non-small Cell Lung Cancer
- Stage IIB Non-small Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer

## Interventions

- **DEVICE:** diffusion-weighted magnetic resonance imaging
- **DEVICE:** 4-dimensional computed tomography
- **RADIATION:** fludeoxyglucose F 18
- **DEVICE:** FDG-PET

## Key facts

- **NCT ID:** NCT02059889
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2016-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059889, "Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02059889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*